Cancer · 1987 · 116 citations · 12 references
PharmacyPharmacotherapySurgeryDrug DeliveryOncologic SurgerySurgical OncologyEmulsion FormulationLipid Emulsion TherapyBleomycin InjectionComparative Clinical TrialsDrug-loaded EmulsionsEmulsion-based FormulationsExperimental StudiesFibrotic ChangeRecurrenceSclerosing Therapy
Of the several types of treatment for cystic hygromas and lymphangiomas, surgical excision has been the preferred treatment. However, there is a high recurrence rate because lymphangiomas tend to infiltrate the surrounding tissues. Bleomycin in a microsphere-in-oil (S/O) emulsion was used in this study as a sclerosing agent for lymphangiomas. Experimental studies using domestic rabbits showed that the bleomycin emulsion caused more marked fibrotic changes at the injection site than other formulations, such as a blank emulsion and bleomycin solution. In clinical trials, 27 of 33 patients received bleomycin S/O emulsion injected directly into the tumors with satisfactory results. Histologic pictures of the clinically resected specimens confirmed the findings of the experimental studies. Comparative studies of treatments between bleomycin S/O emulsion and surgery indicated that injection therapy of bleomycin S/O emulsion would be more beneficial than surgical excisions.
12
Tumors of the Cardiovascular System.
Annals of Internal Medicine · 1980 · 520 citations · Full text
Medicine, Hematology, Immunology +10
A UNIFIED CONCEPT OF LYMPHANGIOMA AND CYSTIC HYGROMA.
Alexander H. Bill, David S. Sumner · PubMed · 1965 · 274 citations
Bleomycin: current Status and New Developments
Helen A. Bush · British Journal of Cancer · 1979 · 196 citations · Full text
Cystic hygroma in children: A report of 126 cases
Tran Ngoc Ninh, Tràn Xuân Ninh, Tràn Xuân Ninh et al. · Journal of Pediatric Surgery · 1974 · 151 citations
Bleomycin treatment for cystic hygroma in children.
Jiro Yura, Takashi Hashimoto, Nobuatsu Tsuruga et al. · PubMed · 1977 · 137 citations